Revolution Medicines, Inc. (RVMD)
176.35
-4.35
(-2.41%)
USD |
NASDAQ |
Nov 12, 16:00
176.07
-0.28
(-0.16%)
After-Hours: 06:50
Revolution Medicines EPS Diluted (Quarterly) : -1.896 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.896 |
| June 30, 2026 | -3.055 |
| March 31, 2026 | -2.291 |
| December 31, 2025 | -1.855 |
| September 30, 2025 | -1.613 |
| June 30, 2025 | -1.314 |
| March 31, 2025 | -1.134 |
| December 31, 2024 | -1.120 |
| September 30, 2024 | -0.9367 |
| June 30, 2024 | -0.8068 |
| March 31, 2024 | -0.7042 |
| December 31, 2023 | -1.144 |
| September 30, 2023 | -0.9927 |
| June 30, 2023 | -0.9197 |
| March 31, 2023 | -0.7181 |
| December 31, 2022 | -0.6338 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.8658 |
| June 30, 2022 | -0.8242 |
| March 31, 2022 | -0.7773 |
| December 31, 2021 | -0.7135 |
| September 30, 2021 | -0.7199 |
| June 30, 2021 | -0.6035 |
| March 31, 2021 | -0.5279 |
| December 31, 2020 | -0.5136 |
| September 30, 2020 | -0.4195 |
| June 30, 2020 | -0.4632 |
| March 31, 2020 | -0.3684 |
| December 31, 2019 | -0.3194 |
| September 30, 2019 | -0.2999 |
| June 30, 2019 | -0.2317 |
| March 31, 2019 | -0.2251 |
| December 31, 2018 | -0.2349 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | 0.3791 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Intellia Therapeutics, Inc. | -0.9094 |
| Twist Bioscience Corp. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -407.46M |
| Revenue (Quarterly) | 197.56M |
| Total Expenses (Quarterly) | 605.02M |
| Enterprise Value | 35.70B |
| Gross Profit Margin (Quarterly) | 97.26% |
| Profit Margin (Quarterly) | -206.2% |
| Earnings Yield | -5.16% |
| Normalized Earnings Yield | -4.742 |